Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They are a another nobody otc company which has convinced investors out of hard earned money and creates loser partnerships with companies like Lannett.
Thats Unelite Pharma in a nutshell.
Effective May 4,2023 LCIN will change to LCINQ, bankruptcy.
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
So how's LCI's stock price Ama~? Did it squeeze for you~? No~?
Make Lannett Great Again
How's that one~?
See, could have had a CEO like this one leading Elite. Which company has a better balance sheet ~?........ Elite. Which CEO is head and shoulders above the other~? Nasrat for sure.
That's the pharma biz though. Only takes a drug or two to take ya down. One bad decision and KA-POW~!
What id unelite?
Good old fashion fire sale!
Hey Unelite Rah Rah’s.
Tell me again how great a RS will be for Unelite?!
Hahaaaaaaaaaa
Take a picture of today. There will be a repeat of this at Unelite. No one should have there surprise faces on when it happens.
Just saw this one!
Hahaaaaaaaaaaaaa
Its exploding alright. Front row ticket to the apocolypse
Done is an understatement.
What happened here?
I know they were delisted - are they done?
thanks
Seriously.
WTF??????
LCI rest in peace
They are hammering it!!!!
The way the stock acts. it's too late - the selling is relentless.
They need a CEO like Nasrat Hakim, or is it too late to save ?
Hahahahahahahahahaha!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Hahahahahahahahahaha!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Hahahahahahahahahaha!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Its trading as LCIN on the pink sheets.
What the hell - LCIN getting crushed!!!!!!!!
Down 64%
NYSE to Suspend Trading Immediately in Lannett Company, Inc. (LCI) and Commence Delisting Proceedings
April 19, 2023, 4:30 PM EDT
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Lannett Company, Inc. (the “Company”) - ticker symbol LCI - from the NYSE. Trading in the Company’s common stock will be suspended immediately.
NYSE Regulation reached its decision to delist the Company’s common stock pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least $15,000,000.
The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the common stock upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.
LCI: SENATE BILL TO STREAMLINE GENERIC DRUG APPROVAL REINTRODUCED
SA Breaking News
LCI losing some good partners
Positive data on insulin glargine coming. Will totally change the trajectory for LCI.
HammerTime !!!!!!!!!!!!!!!!!!!!!!!!!!!!
Any ideas why the jump at 0.90 yesterday???? Serious replys appriciated
I may have to lower my expectations for our fin's on nov.14
Three Months Ended
(In thousands)
September 30,
Medical Indication
2022
2021
Analgesic
$
3,424
$
5,314
Anti-Psychosis
2,620
3,715
Cardiovascular
10,882
14,100
Central Nervous System
20,794
22,785
Endocrinology
7,312
7,845
Gastrointestinal
7,942
15,240
Infectious Disease
5,069
12,515
Migraine
3,324
4,685
Respiratory/Allergy/Cough/Cold
1,202
3,114
Other
8,759
10,352
Contract manufacturing revenue
3,751
1,860
Total net sales
$
75,079
$
101,525
Now pay attention boys and girls
https://finance.yahoo.com/news/1-u-fda-warns-adhd-215548085.html
that means you
lol
I hope so, Nov. should be looking good,
If Lannett is running out of Adderall XR it means that they are selling everything Elite can make.
https://www.bloomberg.com/news/articles/2022-09-19/adderall-shortages-in-us-spread-to-two-more-drug-suppliers?leadSource=uverify%20wall
Hope they called Nasrat to order more, or maybe it's part of the downturn , or separation from Elite, to start reducing orders to clear out the inventory before next March.
I wanted to save this page
https://www.bda.bg/images/stories/documents/bdias/drugs2_list2_1.htm
Hey Nasrat, Hakim, can we talk ?, this is in your future, please take us long for the ride,
Lets not forget how easy it can be to be led by a crazy person into collective hive mind, society , in an instant of time,
we must be careful
My wife was playing some old Harrison tunes and I could not reconize some of the cadence
Looks like Elite got out just in time.
https://finance.yahoo.com/news/news-flash-2-analysts-think-124624362.html
The noose is tightening around LCI
May be time to short this one ?
Products & Pipeline
Drug Market Size Approved Launched Competitors Marketing Partner Notes
Adderall 338 M Yes Yes 11 Lannett 50% owned by Mikah Pharma
Adderall XR 1.5 B Yes Yes 8 Lannett 50% owned by Mikah Pharma
Dantrolene 6.3 M Yes Yes 2 Lannett
Isradipine 5.5 M Yes Yes 1 Epic
Loxapine 5 M Yes Yes 3 Prasco On FDA drug shortage list
Naltrexone 16 M Yes Yes 5 Tagi
Phendimetrazine 4.5 M Yes Yes 4 Elite distributes on their own
Phentermine Capsules 7.5 M Yes Yes 7 Tagi
Phentermine Tablets 40 M Yes Yes 9 Tagi
Trimipramine 2 M Yes Yes 1 Epic
Tylenol with Codeine 45 M Yes No 4 On hold. See latest 10-K.
SunGen Antibiotic #1 85 M No No Unknown Filed. Awaiting FDA approval.
SunGen Antibiotic #2 70 M No No Unknown In negotiations with SunGen
SequestOx Unknown No No Unknown On hold. See latest 10-K.
Undisclosed ANDA #1 Unknown No No Unknown To be filed CY 2022
Undisclosed ANDA #2 Unknown No No Unknown To be filed CY 2022
Undisclosed ANDA #3 Unknown No No Unknown To be filed CY 2022
Undisclosed ANDA #4 Unknown No No Unknown To be filed CY 2022
Undisclosed ANDA #5 Unknown No No Unknown To be filed CY 2023
Undisclosed ANDA #6 Unknown No No Unknown To be filed CY 2023
Undisclosed ANDA #7 Unknown No No Unknown To be filed CY 2023
Undisclosed ANDA #8 Unknown No No Unknown To be filed CY 2023
[/img]
I wanted to save this for future reference , so I put it here.
https://contracts.justia.com/companies/elite-pharmaceuticals-inc-1799/contract/194552/
Lannett just got their generic Adderall tablets approved , now they have both tabs and caps, IR and XR, lets see how they play it,
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=reportsSearch.process
Jun 1, 2022
LANNETT PROVIDES UPDATE ON PIVOTAL CLINICAL TRIAL FOR BIOSIMILAR INSULIN GLARGINE
May 12, 2022
LANNETT ENTERS AGREEMENT TO BE EXCLUSIVE U.S. DISTRIBUTOR OF FLUDARABINE PHOSPATE FOR INJECTION, USP
May 4, 2022
LANNETT REPORTS FISCAL 2022 THIRD-QUARTER FINANCIAL RESULTS
Followers
|
21
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
690
|
Created
|
04/21/02
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |